Cell-line development (CLD), from identifying a biological target to commercially manufacturing a biologic, is a long process and requires extensive planning and resources. There are a number of ...
New approach methodologies (NAMs) – such as organoids, spheroids and microfluidic chip systems – aim to streamline early-stage drug discovery and revolutionize preclinical testing by augmenting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results